India  

Compensation if Covaxin causes serious adverse effect

IndiaTimes Friday, 15 January 2021
Beneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally related to the vaccine. Beneficiaries of Covaxin have to sign a consent form as it has has been approved for restricted use in emergency situations and is supposed to be given in clinical trial mode.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News

Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News 01:05

Bharat Biotech has said that it will pay recipients of the vaccine Covaxin compensation if beneficiaries face any adverse effects after taking it while the vaccine remains in clinical trial mode. Watch the video for more. #Covaxin #BharatBiotech #Vaccine

πŸ’‘ newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairman

Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
IndiaTimes

Covaxin may soon get WHO approval as expert group scheduled to meet next month

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
DNA

Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK Paul

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
DNA

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

You Might Like


Related videos from verified sources

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry [Video]

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost..

Credit: ANI     Duration: 01:30Published
Side effects of Covishield & Covaxin: Simply Explained | Oneindia News [Video]

Side effects of Covishield & Covaxin: Simply Explained | Oneindia News

For vaccines being administered against the Covid-19, some mild adverse reactions may be expected and in certain cases rare adverse events may occur. All of this is detailed in a fact sheet. This is..

Credit: Oneindia     Duration: 02:15Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day Also reported by •IndiaTimes

Bharat Biotech gets permission to manufacture Covaxin for sale

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
Mid-Day Also reported by •IndiaTimesHinduDNA

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being...
IndiaTimes